| <--
Connecticut Biotech |
|
|
Company
Name |
City |
Short
Summary |
| AstraZeneca |
Newark |
AstraZeneca is focused on development of a wide array of both small molecule and biologic medicines. |
| Charles
River Laboratories |
Newark |
Charles River Laboratories is a global provider of solutions that advance the drug discovery and development process. Charles River Laboratories is the
largest laboratory animal production company in
the world, and also offers a number of preclinical and clinical support capabilities. |
| Chespeake PERL |
Newark |
Chesapeake PERL applies its PERLXpress technology platform for production of antibodies, enzymes, viral antigens, and other proteins in whole insect larvae. |
| Hologic |
Newark |
Hologic is focused on the development and commercialization of diagnostic products, medical imaging systems, and surgical products for women's healthcare. |
| iBio |
Newark |
iBio is focused on plant-made products for the prevention and treatment of infectious diseases. |
| SDIX |
Newark |
SDIX is focused on the research, development, and commercialization of antigens, antibodies, and assays for the pharmaceutical and biotechnology markets. |
| BASF |
Newport |
BASF is the worlds largest chemical company, supplying and developing products for many different areas of industrial processses and life sciences. |
| ABS Inc. |
Wilmington |
ABS Inc. is focused on supplying human tissue, custom biological reagents, and cell culture services for biomedical and drug discovery research. |
| Agilent Technologies |
Wilmington |
Agilent
Technologies is a global, diversified technology
company focusing on high-growth markets in the communications,
electronics, life sciences and healthcare industries. |
| AstraZeneca |
Wilmington |
AstraZeneca is focused on development of a wide array of both small molecule and biologic medicines. |
| Biomatik |
Wilmington |
Biomatik is focused on providing research products and services to worldwide life science researchers involved in innovation and discovery. Your one stop for bio-reagents, custom gene, peptide, protein and antibody services. |
| CureDM |
Wilmington |
CureDM is focused on the research of development of therapeutics approaches to restore, maintain and protect new insulin-producing islet structures in patients with diabetes. |
| Incyte |
Wilmington |
Incyte
provides cutting-edge genomics technologies and
products to the biotechnology and pharmaceutical
industries to aid in better and faster prevention,
diagnosis and treatment of disease. |
| Noramco |
Wilmington |
Noramco
is involved in the manufacture of a number of
active pharmaceutical ingredients. |
| Urigen |
Wilmington |
Urigen is focused on the development of products to treat urological conditions such as painful bladder syndrome, urethritis, nocturia, and over active bladder. |
| <--
Connecticut Biotech |
|
